Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 415-420

  Chawla, A ^a   Murphy, G ^b   Donnelly, C ^a   Booth, C L ^a   Johnson, M ^a   Parry, J V ^b   Phillips, A ^a   Geretti, A M ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANIDINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; AGE; AGED; AIDS RELATED COMPLEX; ANTIBODY AVIDITY ASSAY; ANTIGEN BINDING; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IRELAND; KINETICS; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SEROCONVERSION; SERUM; UNITED KINGDOM; VALIDATION PROCESS; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS STRAIN;

ADULT; AGED; ANTIBODY AFFINITY; FEMALE; GUANIDINE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; KINETICS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847008236     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01879-06     Document Type: Article

References (22)

1. Aboudy, Y., B. Barnea, L. Yosef, T. Frank, and E. Mendelson. 2000. Clinical rubella reinfection during pregnancy in a previously vaccinated woman. J. Infect. 41:187-189.
2. + T-cell counts and T-cell function in long-term AIDS-free infection. AIDS 12:1591-1600.
3. CASCADE Collaboration. 2003. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J. Acquir. Immune Defic. Syndr. 34:76-83.
4. Celum, C. L., S. P. Buchbinder, D. Donnell, J. M. Douglas, Jr., K. Mayer, B. Koblin, M. Marmor, S. Bozeman, R. M. Grant, J. Flores, and H. W. Sheppard. 2001. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J. Infect. Dis. 183:23-35.
5. Chargelegue, D., C. M. Stanley, C. M. O'Toole, B. T. Colvin, and M. W. Steward. 1995. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clin. Exp. Immunol. 99:175-181.
6. Dobbs, T., S. Kennedy, C. P. Pau, J. S. McDougal, and B. S. Parekh. 2004. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J. Clin. Microbiol. 42:2623-2628.
7. Dougan, S., B. Patel, J. H. Tosswill, and K. Sinka. 2005. Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west Africa. Sex. Transm. Infect. 81:338-341.
8. Eggers, M., U. Bader, and G. Enders. 2000. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J. Med. Virol. 60:324-330.
9. Gupta, S. B., O. N. Gill, C. Graham, A. D. Grant, P. A. Rogers, and G. Murphy. 2000. What a test for recent infection might reveal about HIV incidence in England and Wales. AIDS 14:2597-2601.
10. Janssen, R. S., G. A. Satten, S. L. Stramer, B. D. Rawal, T. R. O'Brien, B. J. Weiblen, F. M. Hecht, N. Jack, F. R. Cleghorn, J. O. Kahn, M. A. Chesney, and M. P. Busch. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42-48.
11. Kothe, D., R. H. Byers, S. P. Caudill, G. A. Satten, R. S. Janssen, W. H. Hannon, and J. V. Mei. 2003. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J. Acquir. Immune Defic. Syndr. 33:625-634.
12. Martró, E., B. Suligoi, V. Gonzalez, V. Bossi, A. Esteve, J. Mei, and V. Ausina. 2005. Comparison of the avidity index method and the seologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J. Clin. Microbiol. 43:6197-6199.
13. Murphy, G., A. Charlett, L. F. Jordan, N. Osner, O. N. Gill, and J. V. Parry. 2004. HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy. AIDS 18:265-272.
14. Rice, B. D., L. J. Payne, K. Sinka, B. Patel, B. G. Evans, and V. Delpech. 2005. The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003. Sex. Transm. Infect. 81:223-229.
15. Schacker, T. W., J. P. Hughes, T. Shea, R. W. Coombs, and L. Corey. 1998. Biological and virologic characteristics of primary HIV infection. Ann. Intern. Med. 128:613-620.
16. Schwarcz, S., T. Kellogg, W. McFarland, B. Louie, R. Kohn, M. Busch, M. Katz, G. Bolan, J. Klausner, and H. Weinstock. 2001. Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion. Am. J. Epidemiol. 153: 925-934.
17. Sciascia, C., E. Palomba, V. Gay, and P. A. Tovo. 1996. Anti-HIV-1 antibody avidity is correlated with clinical status in infected children. Pediatr. AIDS HIV. Infect. 7:14-19.
18. Suligoi, B., C. Galli, M. Massi, F. Di Sora, M. Sciandra, P. Pezzotti, O. Recchia, F. Montella, A. Sinicco, and G. Rezza. 2002. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. 40:4015-4020.
19. Suligoi, B., M. Massi, C. Galli, M. Sciandra, F. Di Sora, P. Pezzotti, O. Recchia, F. Montella, A. Sinicco, and G. Rezza. 2003. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J. Acquir. Immune Defic. Syndr. 32:424-428.
20. Thomas, H. I., S. Wilson, C. M. O'Toole, C. M. Lister, A. M. Saeed, R. P. Watkins, and P. Morgan-Capner. 1996. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin. Exp. Immunol. 103:185-191.
21. UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. 2001. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 322:1087-1088.
22. Young, C. L., D. J. Hu, R. Byers, S. Vanichseni, N. L. Young, R. Nelson, P. A. Mock, K. Choopanya, R. Janssen, T. D. Mastro, and J. V. Mei. 2003. Evaluation of a sensitive/less sensitive testing algorithm using the bioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res. Hum. Retrovir. 19:481-486.